Immunohistochemical analysis revealed that genistein treatment increased DARPP-32 immunoreactivity and the number of DARPP-32-positive neurons in the striatum of HD mice (Fig. 8d, e). This evidence concerns the gene PPP1R1B and Huntington disease.